A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome.

Status:
Not yet recruiting

Trial end date:
2023-04-15

Target enrollment:

Participant gender:

A Phase 2a, Single-center, randomized, double-blind, placebo-controlled study, in 80 subjects diagnosed with Endometriosis, stage 2-4

Phase 1/Phase 2

Breath of Life International Pharma Ltd